Tavsif
Vincristine Sulfate (Vinkristitin) 1 mg/1 ml solution for intravenous injection — 1,000 vials procured under centralized purchase for treating acute lymphoblastic leukemia, chronic lymphocytic leukemia, multiple myeloma, Waldenström macroglobulinemia, and chronic myeloid leukemia in blast crisis. Budget: 95,000,000 so'm. Deadline: 2026-08-28. Medication must comply with registration documents and State Pharmacopoeia of Uzbekistan; manufacturing facility must hold valid GMP certificate. Primary packaging (vials) and secondary packaging (cardboard boxes) must meet GMP/GDP standards; secondary packaging requires inscription "Sotish man etiladi" in state and Russian languages, plus mandatory digital marking (DataMatrix/QR-code) per Cabinet Resolution №149 (2022-04-02). Drug must be new, unopened, undamaged. Storage conditions per manufacturer instructions and labeling. Transportation via GDP-compliant conditions.
Spetsifikatsiya
Vinsulfat
Buyurtmachi hujjatlari va kontaktlari yashiringan
- Tender hujjatlari
- Buyurtmachi kontaktlari
- Bozor va buyurtmachi bo‘yicha analitika
O'xshash tenderlar
Lot 1 "Siklofosfamid" Gematologiya PQ-4592
Lot 2 "Bendamustin" Gematologiya PQ-4592
Lot 3 "Metotreksat" Gematologiya PQ-4592
Lot 9 "Gansiklovir' Gematologiya PQ-4592
Lot 10 "Protrombin kompleks konsentrati (II, VII,IX,X)" Gematologiya PQ-4592
Valprovoy kislota PP-196
Telegram'da yirik tenderlar
Hafta g'oliblari va eng katta lotlar — har kuni